Caredx Inc [CDNA] stock prices are up 12.32% to $19.05 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CDNA shares have gain 3.59% over the last week, with a monthly amount glided 3.53%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Caredx Inc [NASDAQ: CDNA] stock has seen the most recent analyst activity on January 15, 2025, when Wells Fargo upgraded its rating to a Equal Weight and also revised its price target to $24 from $28. Previously, Wells Fargo started tracking the stock with Underweight rating on August 28, 2024, and set its price target to $28. On August 19, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $40 on the stock. Raymond James downgraded its rating to a Mkt Perform. Craig Hallum upgraded its rating to a Buy but $15 remained the price target by the analyst firm on May 01, 2024. Stephens upgraded its rating to Overweight for this stock on November 09, 2023, but kept the price target unchanged to $10. In a note dated August 15, 2023, Raymond James upgraded an Outperform rating on this stock but restated the target price of $12.
The stock price of Caredx Inc [CDNA] has been fluctuating between $7.42 and $34.84 over the past year. Currently, Wall Street analysts expect the stock to reach $30 within the next 12 months. Caredx Inc [NASDAQ: CDNA] shares were valued at $19.05 at the most recent close of the market. An investor can expect a potential return of 57.48% based on the average CDNA price forecast.
Analyzing the CDNA fundamentals
The Caredx Inc [NASDAQ:CDNA] reported sales of 333.79M for trailing twelve months, representing a surge of 32.04%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.12%, Pretax Profit Margin comes in at 0.19%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.18 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.12 points at the first support level, and at 15.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.55, and for the 2nd resistance point, it is at 22.06.
Ratios To Look Out For
It’s worth pointing out that Caredx Inc [NASDAQ:CDNA]’s Current Ratio is 3.94. Further, the Quick Ratio stands at 3.72, while the Cash Ratio is 1.28. Considering the valuation of this stock, the price to sales ratio is 3.16, the price to book ratio is 2.76 and price to earnings (TTM) ratio is 18.73.
Transactions by insiders
Recent insider trading involved Jain Abhishek, Chief Financial Officer, that happened on Apr 07 ’25 when 265.0 shares were sold. Secretary and General Counsel, Novack Jeffrey Adam completed a deal on Apr 07 ’25 to sell 924.0 shares. Meanwhile, Director Bickerstaff George sold 20000.0 shares on Mar 10 ’25.
